The Effect of Endoscopic Injections of Dextranomer Based Implants on Continence and Bladder Capacity: A Prospective Study of 31 Patients

Abstract

Endoscopic treatment of pediatric structural urinary incontinence with dextranomer implant, a nontoxic, nonimmunogenic, nonmigrant synthétic substance, was effective after 3 years in half of our patients. It may also be beneficial for patients with small bladder functional capacity. As the success rate decreased during the first year of followup, the result observed at 1 year seems to remain stable subsequently.